Literature DB >> 23438622

Disappearance of orthostatic hypotension after pacemaker implantation in a patient with a long PR interval.

Elia De Maria1, Pier Luigi Fontana, Stefano Cappelli.   

Abstract

Orthostatic hypotension is the fall in blood pressure when upright and has a high prevalence in elderly population. Diagnostic and therapeutic work-up can be long and difficult. We describe the case of an 81-year-old male patient with long PR interval and episodes of 2:1 atrioventricular block, in whom the implantation of a dual chamber pacemaker led to the disappearance of orthostatic hypotension. The most likely mechanism was an impaired cardiac filling with a short diastolic time due to a very prolonged PR interval, a somewhat "pseudo-pacemaker syndrome". The correction of the first degree AV block with the implantation of the pacemaker and the optimization of the AV delay allowed us to correct the diastolic impairment and to resume a normal response to orthostatism. This case underlies the complex and multifactorial nature of orthostatic hypotension and the importance of a correct diagnosis of correctable causes to treat a very disabling condition.
Copyright © 2012 Cardiological Society of India. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23438622      PMCID: PMC3860865          DOI: 10.1016/j.ihj.2012.12.006

Source DB:  PubMed          Journal:  Indian Heart J        ISSN: 0019-4832


  13 in total

Review 1.  Autonomic diseases: clinical features and laboratory evaluation.

Authors:  Christopher J Mathias
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-09       Impact factor: 10.154

Review 2.  Clinical practice. Neurogenic orthostatic hypotension.

Authors:  Roy Freeman
Journal:  N Engl J Med       Date:  2008-02-07       Impact factor: 91.245

3.  Guidelines for cardiac pacing and cardiac resynchronization therapy. The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association.

Authors:  Panos E Vardas; Angelo Auricchio; Jean-Jacques Blanc; Jean-Claude Daubert; Helmut Drexler; Hugo Ector; Maurizio Gasparini; Cecilia Linde; Francisco Bello Morgado; Ali Oto; Richard Sutton; Maria Trusz-Gluza
Journal:  Europace       Date:  2007-08-28       Impact factor: 5.214

Review 4.  Evaluation and management of orthostatic hypotension.

Authors:  Jeffrey B Lanier; Matthew B Mote; Emily C Clay
Journal:  Am Fam Physician       Date:  2011-09-01       Impact factor: 3.292

5.  Indications for permanent cardiac pacing in first-degree AV block: class I, II, or III?

Authors:  S S Barold
Journal:  Pacing Clin Electrophysiol       Date:  1996-05       Impact factor: 1.976

Review 6.  Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology.

Authors: 
Journal:  Neurology       Date:  1996-05       Impact factor: 9.910

7.  Inhibition of ventricular stimulation in patients with dual chamber pacemakers and prolonged AV conduction.

Authors:  F Bode; U Wiegand; H A Katus; J Potratz
Journal:  Pacing Clin Electrophysiol       Date:  1999-10       Impact factor: 1.976

Review 8.  [The pseudo-pacemaker syndrome].

Authors:  R Kuniyoshi; E Sosa; M Scanavacca; M Martinelli; L Magalhães; D Hachul; A Lewandowski; A Sarabanda; G Bellotti; F Pileggi
Journal:  Arq Bras Cardiol       Date:  1994-08       Impact factor: 2.000

9.  First-degree atrioventricular block. Clinical manifestations, indications for pacing, pacemaker management & consequences during cardiac resynchronization.

Authors:  S Serge Barold; Arzu Ilercil; Fabio Leonelli; Bengt Herweg
Journal:  J Interv Card Electrophysiol       Date:  2007-03-02       Impact factor: 1.900

10.  Apparent P wave undersensing in a DDD pacemaker post exercise.

Authors:  B M van Gelder; R van Mechelen; K den Dulk; M I el Gamal
Journal:  Pacing Clin Electrophysiol       Date:  1992-11       Impact factor: 1.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.